Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 677,911 | 879,891 | 570,119 | 642,951 | 748,953 |
| Marketable Securities | 42,249 | 60,295 | 17,363 | 2,991 | 7,939 |
| Receivables | 254,484 | 205,226 | 139,444 | 116,518 | 76,868 |
| Inventories | 52,842 | 32,980 | 26,753 | 24,527 | 18,277 |
| TOTAL | $1,093,138 | $1,241,306 | $797,749 | $839,382 | $912,277 |
| Non-Current Assets | |||||
| PPE Net | 5,226 | 4,941 | 5,366 | 5,830 | 6,107 |
| Investments And Advances | 55,095 | 61,529 | 79,972 | 92,168 | 108,002 |
| Intangibles | 26,641 | 27,359 | 28,077 | 28,795 | 29,513 |
| Other Non-Current Assets | 37,199 | 35,846 | 24,861 | 32,075 | 24,291 |
| TOTAL | $124,161 | $129,675 | $138,276 | $158,868 | $167,913 |
| Total Assets | $1,217,299 | $1,370,981 | $936,025 | $998,250 | $1,080,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 27,202 | 29,058 | 36,228 | 18,702 | 26,134 |
| Accrued Expenses | 114,444 | 93,768 | 118,139 | 90,774 | 68,482 |
| Other current liabilities | 192,186 | 135,509 | 120,222 | 92,743 | 65,916 |
| TOTAL | $890,648 | $816,372 | $287,971 | $216,600 | $175,854 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,927,533 | 1,926,078 | 1,852,470 | 1,851,016 | 1,849,559 |
| Deferred Revenues | 5,546 | 6,115 | 7,190 | 9,087 | 10,540 |
| Other Non-Current Liabilities | 897,244 | 887,191 | 860,287 | 842,449 | 819,939 |
| TOTAL | $2,831,526 | $2,822,533 | $2,724,065 | $2,704,402 | $2,682,310 |
| Total Liabilities | $3,722,174 | $3,638,905 | $3,012,036 | $2,921,002 | $2,858,164 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 195,488 | 195,861 | 193,863 | 192,709 | 191,169 |
| Common Shares | 206 | 204 | 202 | 200 | 198 |
| Retained earnings | -4,137,453 | -3,985,237 | -3,821,194 | -3,628,331 | -3,445,588 |
| Other shareholders' equity | 10,054 | 10,655 | 10,335 | 10,044 | 9,611 |
| TOTAL | $-2,504,875 | $-2,267,924 | $-2,076,011 | $-1,922,752 | $-1,777,974 |
| Total Liabilities And Equity | $1,217,299 | $1,370,981 | $936,025 | $998,250 | $1,080,190 |